Seattle company gets green light for human tests on potential COVID-19 cure


The Seattle based infectious disease research institute will soon begin trials on an investigational immunotherapy that could be a promising treatment option for covert nineteen it's based on immune cells in the body known as natural killer in case cells which are already used to treat leukemia multiple myeloma patients the immune cells to get the sites of active via affection kill the virus in induce an immune response that controls the if infection the trial will begin soon with approximately a hundred patients diagnosed with a coded nineteen infection

Coming up next